Instil Bio, Inc.

NASDAQ (USD): Instil Bio, Inc. (TIL)

Last Price

33.38

Today's Change

-0.25 (0.74%)

Day's Change

33.09 - 36.08

Trading Volume

166,052

Overview

Market Cap

217 Million

Shares Outstanding

6 Million

Avg Volume

285,792

Avg Price (50 Days)

42.10

Avg Price (200 Days)

19.04

PE Ratio

-1.82

EPS

-18.39

Earnings Announcement

12-Nov-2024

Previous Close

33.63

Open

33.70

Day's Range

33.09 - 36.08

Year Range

6.08 - 92.0

Trading Volume

166,147

Price Change Highlight

1 Day Change

-0.74%

5 Day Change

36.24%

1 Month Change

-20.66%

3 Month Change

215.50%

6 Month Change

188.26%

Ytd Change

329.60%

1 Year Change

363.61%

3 Year Change

-91.93%

5 Year Change

-93.69%

10 Year Change

-93.69%

Max Change

-93.69%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment